Dajo Bio
Latest round
- Seed
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 3
About Dajo Bio
, trading as Dajo Bio, operates in innovative drug research and development, targeting autoimmune diseases and solid tumors through precision immunotherapy technologies. The company’s core products are next-generation TCR protein drug candidates supported by its proprietary FleXi-T affinity optimization platform, Full-Scanning safety assessment system, and T-Lock bispecific long-acting TCR platform. The company primarily generates revenue from the research, development, and future commercialization of TCR-based therapeutic products and related biotechnology innovations.
Who invested in Dajo Bio
3 investors across 1 round
See all investors in Dajo Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 17, 2026
Amount
Undisclosed
Investors
Questions about Dajo Bio
Who invested in Dajo Bio?
Dajo Bio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dajo Bio raised?
Dajo Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dajo Bio last raise money?
Dajo Bio's most recent round on record is a Seed, in Aug 2026.
What does Dajo Bio do?
, trading as Dajo Bio, operates in innovative drug research and development, targeting autoimmune diseases and solid tumors through precision immunotherapy technologies.
Where is Dajo Bio headquartered?
Dajo Bio is headquartered in Shenzhen, China.
Which VCs invest in companies like Dajo Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Dajo Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Dajo Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.